Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 78.32M
22.87x1.92x-17.12x3.16x11.21x18.4x1.72% 67.84B
10.51x11.12x0.06x5.41x8.33x9.14x - 8.39B
15.74x1.36x0.77x1.97x6.77x8.16x2.83% 7.92B
22.63x6.17x1.54x6.67x18.24x19.04x-.--% 4.53B
42.42x2.53x-1.38x2.4x29.26x43.35x0.72% 3.72B
28.24x - 0.18x5.41x15.46x25.04x - 3.28B
105.12x - -0.64x - - - -.--% 2.64B
48.28x7.57x-1.25x16.29x34.21x40.24x - 1.02B
12.38x0.82x0.88x1.1x27.74x-75.56x4.13% 1B
-7.41x12.39x0.45x204.79x-6.59x-5.16x-.--% 963M
-65.86x1.6x0.99x - - - - 885M
44.39x - -0.08x - - - - 880M
Average 23.27x 5.05x -1.30x 27.47x 16.07x 9.18x 1.34% 7.93B
Weighted average by Cap. 23.58x 3.05x -11.19x 5.54x 11.99x 17.02x 1.65%
Specialty & Advanced Pharmaceuticals
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!